Home › NDC Lookup › Ingredients › Undecylenic Acid › 63347-0600-01
TERPENICOL ANTIFUNGAL UNDECYLENIC ACID 25 g/100mL Liquid, 37.5 mL — NDC 63347-0600-01 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

TERPENICOL ANTIFUNGAL UNDECYLENIC ACID 25 g/100mL Liquid, 37.5 mL — NDC 63347-600-01 (Billing 63347-0600-01)

by Blaine Labs Inc. · 37.5 mL in 1 JAR

This is a package of 37.5 mL of TERPENICOL ANTIFUNGAL UNDECYLENIC ACID 25 g/100mL Liquid from Blaine Labs Inc., marketed since Apr 2014 and currently FDA-listed. It is this product's only package size.

NDC 63347-0600-01
🏷️ FDA NDC (as labeled) 63347-600-01 billing pads the product segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

🚨
Active recall for this product.
Class II · Apr 8, 2026 — CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry (Blaine Labs Inc) · FDA recall D-0697-2026
Lots / codes: Lots BL3411R, Exp Date 06/08/2027, BL3468, Exp Date 03/07/2027, & BL3535, Exp Date 09/25/2027. · reported Jul 8, 2026
Check your lot/expiration against the official notice — look up the recall number in the FDA recall database ↗
⚠️
Other active recalls for Undecylenic Acid (different manufacturers) — 2 · tap to view
These affect other manufacturers’ products for the same ingredient — not necessarily the exact NDC on this page.
Class II · Apr 8, 2026 — CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry (Blaine Labs Inc) · FDA recall D-0694-2026
Class II · Apr 8, 2026 — CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry (Blaine Labs Inc) · FDA recall D-0695-2026
Each entry is an official FDA enforcement report — look up any recall number in the FDA recall database ↗

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 63347-600-01
Product NDC 63347-600
11-digit billing NDC 63347060001
RxCUI 998329, 2745978
UNII K3D86KJ24N
Application # M005
SPL Set ID a020334e-aac9-4ea5-a0ea-8e5b021fe2eb
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2014-04-01
Route TOPICAL
Dosage form LIQUID
Substance UNDECYLENIC ACID
Quick answers
  • RxCUI (RxNorm): 998329
Why two NDCs? The FDA registers this code as 63347-600-01 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 63347-0600-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Other antifungals for topical use class.

Drug family (ATC) Other antifungals for topical use
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

📗 Our plain-language guide HelloPharmacist
  • It treats three common fungal skin infections: athlete's foot (the itchy, scaly condition that affects the feet and toes), jock itch (a fungal rash in the groin area), and ringworm...
  • What exactly does undecylenic acid treat?
  • For athlete's foot and ringworm, most products are used daily for 4 full weeks. For jock itch, 2 weeks of daily use is typically recommended. Some nail products note that visible i...
  • That depends on the product. Most undecylenic acid creams, sprays, and general topical solutions are not effective on nails and should not be used there. However, some products — l...
📖 Read our full Undecylenic guide →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer mLPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
63347-0600-01 You're viewing this Main listing 37.5 mL in 1 JAR 2014-04-01 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Undecylenic Acid 25 g/100mL 49283-0025-05 Chemco 15 ml — — FDA listed —
Antifungal 25 g/100mL 49283-0250-05 Chemco 15 ml — — FDA listed —
Myco Nail A Antifungal Solution 250 mg/mL 52083-0242-30 Kramer 1 bottle — — FDA listed —
Hongo Killer 25 mg/100mL 58593-0826-01 Efficient 30 ml — — FDA listed —
Terpenicol Antifungal 25 g/100mLthis 63347-0600-01 Blaine 37.5 ml — — FDA listed —
Premier Value Antifungal Maximum Strength 25 mg/30mL 68016-0474-00 PHARMACY 30 ml — — FDA listed —
ELON Dual Defense Anti Fungal Formula 250 mg/mL 71171-0778-15 Little 1 bottle — — FDA listed —
Human Science Antifungal Foot Care 250 mg/mL 71356-0156-01 HUMAN 30 ml — — FDA listed —
Tripenicol S .25 g/mL 73352-0550-01 Trifluent 37.5 ml — — FDA listed —
Bldaxn Nail Repair Pen .25 g/mL 76986-0022-01 Guangdong 3 bottles — — FDA listed —
Nerante Fungus Nail Pen .25 g/mL 76986-0030-01 Guangdong 6 tubes — — FDA listed —
Fungal Nail Treatment .25 g/mL 76986-0031-01 Guangdong 30 ml — — FDA listed —
FLUSH Maximum Strength Antifungal formula 250 mg/mL 80569-0084-15 Triple 15 ml — — FDA listed —
Antifungal Treatment Liquid 25 undeclylenic Acid 250 mg/mL 83691-0000-00 SANSAR, 1 bottle — — FDA listed —
Foot Cure Nail Repair Pen 25 g/100mL 83691-0011-01 SANSAR, 4 applicators — — FDA listed —
Omzok Antifungal Pen 25 g/100mL 83804-0007-01 Shenzhen 5 applicators — — FDA listed —
WRFAATGO ANTIFUNGAL Pen Undecylenic Acid 25% .25 g/mL 83804-0012-01 Shenzhen 5 tubes — — FDA listed —
Pharmbanner Fungal Nail Renewal 25 g/100mL 83818-0019-01 Shenzhen 2 bottles — — FDA listed —
MEOLY Fungal Nail Renewal 25 g/100mL 83818-0026-01 Shenzhen 2 bottles — — FDA listed —
Fungal Nail Renewal 25 g/100mL 84007-0130-01 Medhome 30 ml — — Discontinued —
Klipp EXTRA STRENGTH TOENAIL FUNGUS TREATMENT 25 g/100mL 84558-0018-01 GUANGZHOU 30 ml — — FDA listed —
Klipp Fungal Nail Treatment 25 g/100mL 84558-0019-01 GUANGZHOU 30 ml — — FDA listed —
Nail Repair Pen .25 g/mL 84763-0008-01 Yunqi 8 tubes — — FDA listed —
Antifungal Toenail Fungus Pen .25 g/mL 84763-0009-01 Yunqi 12 ml — — FDA listed —
Fungal Nail Repair Pen .25 g/mL 84763-0011-01 Yunqi 5 bottles — — FDA listed —
Antifungal Pen 25 g/100mL 84896-0008-01 Guangzhou 15 ml — — FDA listed —
Nail Extra Strength Repair Pen 25 g/100mL 84896-0009-01 Guangzhou 12 ml — — FDA listed —
Antifungal Pen 25 g/100mL 85210-0001-01 XF 1 applicator — — FDA listed —
South Beach Multi-Purpose Nail Repair 25 g/100mL 85214-0025-05 SOUTH 1 bottle — — FDA listed —
Bldaxn FUNGAL NAIL RENEWZL 25 g/100mL 85248-0029-01 Jiangxi 2 bottles — — FDA listed —
Puvida Fungal Nail Renewal 25 g/100mL 85248-0090-01 Jiangxi 30 ml — — FDA listed —
ViLLsure Antifungal Pen 25 g/100mL 85248-0151-01 Jiangxi 5 tubes — — FDA listed —
Serynth Antifungal Nail Treatment Pen 25 g/100mL 85248-0165-01 Jiangxi 2.5 ml — — FDA listed —
LYSSERA Fungal Nail Renewal 25 g/100mL 85248-0174-01 Jiangxi 4 tubes — — FDA listed —
Werpeka Fungal Nail Renewal 25 g/100mL 85248-0184-01 Jiangxi 2.5 ml — — FDA listed —
Toyknier Multi-Purpose Treatment 25 g/100mL 85248-0187-01 Jiangxi 30 ml — — FDA listed —
Minadcin Toenail Fungus Pen 25 g/100mL 85248-0199-01 Jiangxi 5 tubes — — FDA listed —
Beukow Antifungal Pen 25 g/100mL 85248-0200-01 Jiangxi 4 tubes — — FDA listed —
Kakalsa TOENAIL FUNGUS TREATMENT 25 g/100mL 85248-0204-01 Jiangxi 4 tubes — — FDA listed —
Avenaster Fungal Nail Care Duo Set (Night) 25 g/100mL 85248-0214-01 Jiangxi 3 tubes — — FDA listed —
TrpWinner TOENAIL FUNGUS PEN 25 g/100mL 85248-0218-01 Jiangxi 4 ml — — FDA listed —
Cyyzrose Antifungal Nail 25 g/100mL 85248-0222-01 Jiangxi 3 tubes — — FDA listed —
Bodykoo Nail Fungus Treatment 25 g/100mL 85248-0227-01 Jiangxi 15 ml — — FDA listed —
Sovs Fungal Nail Repair Renewal 25 g/100mL 85248-0232-01 Jiangxi 30 ml — — FDA listed —
Fungal Nail Treatment 25 g/100mL 85308-0002-01 Gaoye 30 ml — — Discontinued —
Fungal Nail Treatment 25 g/100mL 85308-0003-01 Gaoye 30 ml — — Discontinued —
Toenail Fungus Treatment 25 g/100mL 85569-0005-01 100 30 ml — — FDA listed —
Tegasolve Toenail Fungus Treatment 25 g/100mL 85578-0003-01 Zhengzhou 1 bottle — — FDA listed —
OetMoe Antifungal Solution 250 mg/mL 85636-0007-01 Shenzhen 20 ml — — FDA listed —
Bee Venom Toenail Fungus Treatment 250 mg/mL 85636-0008-01 Shenzhen 20 ml — — FDA listed —
Bee Venom Toenail Fungus Treatment 250 mg/mL 85636-0011-01 Shenzhen 20 ml — — FDA listed —
Tobcharm Fungus Nail Renewal 25 g/100mL 85817-0005-01 Guangzhou 2 bottles — — FDA listed —
Arflom Toenail Fungus Treatment Liquid 25 g/100mL 85817-0006-01 Guangzhou 2 bottles — — FDA listed —
VTROUY Fungus Nail Renewal 25 g/100mL 85817-0007-01 Guangzhou 2 bottles — — FDA listed —
FUNGLARA Anti Fungal 250 mg/mL 87028-0876-00 FUNGLARA 15 ml — — FDA listed —
Nail Fungal Pen 25 g/100g 87298-0015-01 Guangzhou 3 g — — FDA listed —
Toenail Fungus Pen 25 g/100g 87298-0016-01 Guangzhou 3 g — — FDA listed —
CuraNails Antifungal Pen 25 g/100mL 87300-0001-01 Quality 3 applicators — — FDA listed —
Lakeim Fungal Nail Repair Pen 25 g/100mL 87408-0007-01 Guangzhou 3 tubes — — FDA listed —
Lakeim FUNGAL NAIL RENEWAL Kit 25 g/100mL 87408-0009-01 Guangzhou 2 bottles — — FDA listed —
OSIMOON Fungal Nail Treatment 25 g/100mL 87408-0014-01 Guangzhou 2 bottles — — FDA listed —
Uauko Fungal Nail Treatment 25 g/100mL 87408-0018-01 Guangzhou 2 bottles — — FDA listed —
VTROUY Fungal Nail Renewal Pen 25 g/100mL 87408-0023-01 Guangzhou 3 tubes — — FDA listed —
YEARCHOICE Fungal Nail Repair Pen 25 g/100mL 87408-0024-01 Guangzhou 3 tubes — — FDA listed —
Assielf Antifungal Pen 25 g/100mL 87418-0002-01 Shenzhen 3 tubes — — FDA listed —
Zynthix 1 g/4mL 87575-4041-01 Shenzhen 3 applicators — — FDA listed —
Venrock 25 g/100mL 85772-0009-01 Guangzhou 1 bottle — — FDA listed —
Foot Choice-Nail Fungal Pen 25 g/100mL 87830-0001-01 Foot 2 applicators — — FDA listed —
Persiancat ANTIFUNGAL PEN 25 g/100mL 85593-0130-01 Guangzhou 3 vials — — FDA listed —
FGPER Topical Antifungal Pen 25 g/100mL 85593-0126-01 Guangzhou 4 applicators — — FDA listed —
Pureskin Antifungal Pen 25 g/100mL 87217-0004-01 BENLONG 4 applicators — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2014
On the market since
Apr 2014
📍
2026
Currently FDA-listed
12 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerBlaine Labs Inc.
FDA applicationM005 (OTC MONOGRAPH DRUG)
Labeler code63347
First marketedApr 2014
Product typeHuman Otc Drug
Portfolio14 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose
🎯 Indications and Usage 33 words ▾

INDICATIONS CURES MOST ATHLETE'S FOOT (TINEA PEDIS) CURES MOST JOCK ITCH (TINEA CRURIS) AND RELIEVES ITCHING, CRACKING, BURNING AND SCALING, WHICH ACCOMPANY THESE CONDITIONS PREVENTS MOST ATHLETE'S FOOT (TINEA PEDIS) WITH DAILY USE

⏱️ Dosage and Administration 93 words ▾

DIRECTIONS WASH THE AFFECTED AREA WITH SOAP AND WATER, DRY THOROUGHLY, THEN APPLY A HEAVY LAYER OVER THE AFFECTED AREA. USE TWICE DAILY (MORNING AND NIGHT) OR AS DIRECTED BY A PHYSICIAN SUPERVISE CHILDREN IN THE USE OF THIS PRODUCT FOR ATHLETE'S: PAY SPECIAL ATTENTION TO SPACES BETWEEN TOES ; WEAR WELL-FITTING, VENTILATED SHOES AND CHANGE SOCKS AT LEAST ONCE, DAILY FOR ATHLETE'S FOOT AND RINGWORM, USE DAILY FOR FOUR (4) WEEKS. FOR JOCK ITCH, USE DAILY FOR TWO (2) WEEKS.

IF CONDITION PERSISTS LONGER, CONSULT A PHYSICIAN WASH HANDS AFTER EACH USE

⚠️ Warnings 28 words ▾

WARNINGS DO NOT USE: ON CHILDREN UNDER 2 YEARS OF AGE UNLESS DIRECTED BY A PHYSICIAN IN OR NEAR THE MOUTH OR THE EYES FOR VAGINAL YEAST INFECTIONS

🧪 Active Ingredient 9 words ▾

ACTIVE INGREDIENT DRUG FACTS ACTIVE INGREDIENT UNDECYLENIC (10-UNDECENOIC) ACID

🧪 Inactive Ingredients 52 words ▾

INACTIVE INGREDIENTS OTHER INGREDIENTS CYMOPHENOL (CARVACROL), UREA, AQUA (WATER), ORGANIC VULGARE (WILD OREGANO) ESSENTIAL OIL, VITIT VINFER (GRAPE) SEED OIL, POLYSORBATE 20, GLYCERYL STEARATE, PROPYLENE GLYCOL, UREA, GLYCERIN, CETYL ALCOHOL, POLYETHYLENE GLYCOL COCOATE, SORBITAN LAURATE, POLYETHYLENE GLYCOL DICOCOATE, POLYETHYLENE GLYCOL, FATTY ACIDS, COCO, LAURETH-4, HYDROXYETHYLCELLULOSE, PHENOXYETHANOL CAPRYLY ALCOHOL, ETHYLHEXYL GLYCERIN, HEXYLENE GLYCOL

🎯 Purpose 2 words ▾

PURPOSE ANTIFUNGAL

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for TERPENICOL ANTIFUNGAL (this brand).

Top reported reactions

Treatment Failure3
Intentional Dose Omission2
Nausea2
Vision Blurred2
Abdominal Discomfort1
Abdominal Pain Upper1
Ankle Fracture1

Age at onset

Adult1
Elderly1

Reporter sex

20 reports
Male · 50%
Female · 50%

Serious outcomes

Hospitalization6
Life-threatening1
Death1
Reports over time (by year) — tap or hover for the count & year
2020 2022 2024 2026 3 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Blaine Labs Inc.. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
Blaine Labs Inc. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 63347-0511-03 · Blaine 63347-0601-01 · Blaine →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.